Abivax S.A.
ABVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001956827
No open-market purchases or sales by Abivax S.A. insiders were filed in the last 90 days; 303 institutions reported holding it in 13F filings for Q2 2026, worth $7.18B in total; Maverick Capital is the only superinvestor holding it.
Other share classesAAVXF
13F holders, Q2 2025
Institutional positions in Abivax S.A. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- −3 vs. Q1 2025
- Shares held
- 30.7M
- −1.10M (−3.5%) vs. Q1 2025
- Total value
- $234.6M
- +$36.1M (+18.2%) vs. Q1 2025
- New holders
- 6
- 16 more added
- Sold out
- 9
- 11 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 303 | $7.18B |
| Q1 2026 | 254 | $5.53B |
| Q4 2025 | 247 | $7.61B |
| Q3 2025 | 165 | $4.41B |
| Q2 2025 | 43 | $234.6M |
| Q1 2025 | 46 | $198.5M |
| Q4 2024 | 48 | $218.6M |
| Q3 2024 | 40 | $312.8M |
| Q2 2024 | 38 | $371.6M |
| Q1 2024 | 36 | $334.2M |
| Q4 2023 | 30 | $227.8M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Abivax S.A.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EverSource Wealth Advisors, LLC | 8 | $61 | 0.00% | +8 | New |
| Principal Securities, Inc. | 36 | $275 | 0.00% | +26+260.0% | Added |
| Financial Management Professionals, Inc. | 100 | $765 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 536 | $4.10K | 0.00% | −10,170−95.0% | Reduced |
| GAMMA Investing LLC | 645 | $4.93K | 0.00% | −2,368−78.6% | Reduced |
| Rhumbline Advisers | 981 | $7.50K | 0.00% | +243+32.9% | Added |
| Hurley Capital, LLC | 3,015 | $23.1K | 0.02% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 10,670 | $81.6K | 0.00% | −776−6.8% | Reduced |
| Guggenheim Capital LLC | 16,097 | $123.1K | 0.00% | +2,305+16.7% | Added |
| Geode Capital Management, LLC | 16,818 | $128.7K | 0.00% | +69+0.4% | Added |
| XTX Topco Ltd | 18,194 | $139.2K | 0.01% | +18,194 | New |
| Quadrature Capital Ltd | 19,367 | $148.2K | 0.00% | +19,367 | New |
| GWM Advisors LLC | 30,000 | $229.5K | 0.00% | +30,000 | New |
| HighVista Strategies LLC | 51,156 | $391.3K | 0.14% | +2,092+4.3% | Added |
| J. Goldman & Co LP | 67,500 | $516.4K | 0.02% | +67,500 | New |
| StemPoint Capital LP | 87,748 | $671.3K | 0.22% | +87,748 | New |
| Paloma Partners Management Co | 95,130 | $727.7K | 0.17% | +56,681+147.4% | Added |
| Affinity Asset Advisors, LLC | 100,000 | $765.0K | 0.11% | −100,000−50.0% | Reduced |
| Barclays PLC | 113,391 | $867.4K | 0.00% | +111,913+7,571.9% | Added |
| Soleus Capital Management, L.P. | 125,000 | $956.3K | 0.07% | 00.0% | Unchanged |
| Allostery Investments LP | 167,350 | $1.28M | 16.31% | −932,304−84.8% | Reduced |
| UBS Group AG | 167,656 | $1.28M | 0.00% | +5,102+3.1% | Added |
| Point72 Asset Management, L.P. | 167,887 | $1.28M | 0.00% | +138,469+470.7% | Added |
| Citigroup Inc | 170,733 | $1.31M | 0.00% | −13,506−7.3% | Reduced |
| Woodline Partners LP | 183,800 | $1.41M | 0.01% | −18,124−9.0% | Reduced |
| Kennedy Capital Management, Inc. | 241,188 | $1.85M | 0.04% | +15,997+7.1% | Added |
| Ensign Peak Advisors, Inc | 455,684 | $3.49M | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 475,280 | $3.64M | 0.00% | −21,873−4.4% | Reduced |
| Saturn V Capital Management LLC | 622,479 | $4.76M | 1.93% | +69,553+12.6% | Added |
| Standard Life Aberdeen plc | 710,516 | $5.44M | 0.01% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 870,438 | $6.66M | 0.21% | +299,770+52.5% | Added |
| Millennium Management LLC | 1,251,765 | $9.58M | 0.01% | +264,351+26.8% | Added |
| Citadel Advisors LLC | 1,252,257 | $9.58M | 0.01% | −121,603−8.9% | Reduced |
| Octagon Capital Advisors LP | 1,267,000 | $9.69M | 2.13% | +37,000+3.0% | Added |
| Great Point Partners LLC | 1,291,617 | $9.88M | 6.42% | −346,494−21.2% | Reduced |
| VR Adviser, LLC | 1,345,780 | $10.3M | 0.77% | 00.0% | Unchanged |
| Franklin Resources Inc | 1,371,050 | $10.5M | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,482,994 | $11.3M | 0.80% | 00.0% | Unchanged |
| Caligan Partners LP | 1,674,400 | $12.8M | 2.49% | +405,281+31.9% | Added |
| Cormorant Asset Management, LP | 2,130,000 | $16.3M | 1.21% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 3,071,340 | $23.5M | 3.82% | +861,321+39.0% | Added |
| Deep Track Capital, LP | 3,480,144 | $26.6M | 0.86% | −99,065−2.8% | Reduced |
| TCG Crossover Management, LLC | 6,056,596 | $46.3M | 5.29% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −907,679−100.0% | Sold out |
| Samsara BioCapital, LLC | 0 | $0 | 0.00% | −425,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −220,845−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −210,901−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −74,841−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −52,829−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,152−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −2,660−100.0% | Sold out |